Covid-19: Oxford vaccine's for corona final human trial to be held at five locations in India,

COVID-19 OXFORD VACCINE STATUS FOR TRIAL  

Preparations have been completed at five locations in India for the third and final phase of the Covid-1V Vision, developed b y Oxford-AstraZeneca. Information was given by Renu Swaroop, Secretary, Department of Biotechnology. He said it was a necessary step and should be made available in the country first before vaccinating Indians.

Oxford University and RA Strazeneka are the lime of the India Serum Institute (SII) for vaccine production. The results of the previous two-phase trials have already been published.

The Serum Institute is preparing for the third phase of BCG clinical trials to see if the BCG vaccine is effective in boosting the immune system.

According to Renu Swaroop, DBT is part of an effort to facilitate the approval of exchanges or give access to various networks in the country, whether it is financial aid for any Covid-1 vaccine in India. Now that DBT Phase III is setting up clinical trials and work has begun, five sites are ready.